Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation

Summary

The primary objective of this study is to determine whether 4 grams daily of mycophenolate mofetil (MMF) results in a greater proportion of individuals adequately exposed as measured by drug levels (area under the curve of \> 40 mg\*hr/L).

Timeline

Start

2010-02

Primary completion

2012-02

Completion

2012-02

Publications

• Kiberd BA, Lawen J, Daley C. Limits to intensified mycophenolate mofetil dosing in kidney transplantation. Ther Drug Monit. 2012 Dec;34(6):736-8. doi: 10.1097/FTD.0b013e31826d7bfa.

Drugs

Indications